To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CHRAC1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
181 supporting clones for gene CHRAC1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA647606   CHRAC1.a 1 to 554 9 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA887467   CHRAC1.a 1 to 561 9 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
NM_017444.4   CHRAC1.a 1 to 2496 5 to 2500 exact RefSeq,   2500/2500
(100 %)
0 diff
(100 %id)
DB257787 uterus CHRAC1.a 1 to 572 5 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BI545550 brain, hippocampus CHRAC1.a 1 to 821 3 to 828 K69T K70E V71S L72T T73D ...     828/831
(99 %)
44 diff
(94.8 %id)
TI_44165628   CHRAC1.a 1 to 821 88 to 913 K69T K70E V71S L72T T73D ...     828/916
(90 %)
47 diff
(94.9 %id)
AK023537 placenta CHRAC1.a 1 to 2496 2 to 2496 exact tiling clone, available from FLJ,   2496/2496
(100 %)
7 diff
(99.8 %id)
AU136132 placenta CHRAC1.a 1 to 771 2 to 768 D115X capped   767/774
(99 %)
8 diff
(99.0 %id)
BG532547 embryonal carcinoma, testis CHRAC1.a 2 to 640 1 to 653 I37N N38Q Q39P E40G A41G ...     653/658
(99 %)
13 diff
(98.1 %id)
DB482001 hippocampus CHRAC1.a 4 to 489 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
BX437855 neuroblastoma CHRAC1.a 6 to 1020 1 to 1007 D125X     1007/1059
(95 %)
15 diff
(98.6 %id)
TI_159676521   CHRAC1.a 10 to 963 43 to 984 exact     942/1039
(90 %)
18 diff
(98.3 %id)
CF132290 Chondrosarcoma Lung Metastasis cell lines, lung CHRAC1.a 11 to 759 1 to 749 exact     749/749
(100 %)
0 diff
(100 %id)
BG170848 hypernephroma, cell line, Kidney CHRAC1.a 12 to 524 1 to 511       511/800
(63 %)
4 diff
(99.5 %id)
BG258447 embryonal carcinoma, cell line, testis CHRAC1.a 14 to 843 1 to 825 K111H R112E E113G E114R D115R ...     825/1056
(78 %)
36 diff
(96.6 %id)
BG717049 testis CHRAC1.a 26 to 672 1 to 647 exact     647/647
(100 %)
3 diff
(99.6 %id)
CD250220 embryonic stem cells, WA01, passage 38 CHRAC1.a 33 to 554 25 to 555       529/1020
(51 %)
19 diff
(98.2 %id)
AL553048 placenta, Placenta Cot 25-normalized CHRAC1.a 34 to 1091 1 to 1045 exact fully sequenced,   1045/1045
(100 %)
24 diff
(97.8 %id)
AW269046 pooled CHRAC1.a 37 to 342 8 to 313     Submitted on the opposite strand 306/490
(62 %)
2 diff
(99.6 %id)
BX459025 placenta CHRAC1.a 38 to 1187 1 to 1135 exact     1135/1138
(99 %)
20 diff
(98.3 %id)
BG285306 adenocarcinoma, cell line, Prostate CHRAC1.a 38 to 807 1 to 769 K67T E68G K70E V71S L72T ...     769/972
(79 %)
10 diff
(99.0 %id)
BM550990 duodenal adenocarcinoma, cell line, small intestine CHRAC1.a 38 to 841 1 to 817 exact     817/1239
(65 %)
29 diff
(97.7 %id)
CT004476 T-Lymphocytes CHRAC1.a 38 to 476 1 to 443       442/443
(99 %)
4 diff
(99.1 %id)
BX340936   CHRAC1.a 49 to 950 1 to 902 exact     902/902
(100 %)
2 diff
(99.8 %id)
AW269037 pooled CHRAC1.a 71 to 342 1 to 272     Submitted on the opposite strand 272/452
(60 %)
2 diff
(99.6 %id)
BP353821   CHRAC1.a 110 to 691 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
TI_57180694   CHRAC1.a 111 to 898 57 to 842 K111Q R112E E113G E114R D115R ...     786/842
(93 %)
11 diff
(98.7 %id)
BI766796 pooled lung and spleen CHRAC1.a 120 to 898 1 to 778 K111Q R112E E113G E114R D115R ...     778/778
(100 %)
6 diff
(99.3 %id)
BQ441794 embryonal carcinoma, cell line, testis CHRAC1.a 122 to 854 1 to 739 exact     739/896
(82 %)
8 diff
(99.2 %id)
CN360557 embryonic stem cells, cell lines H1, H7, andH9 CHRAC1.a 125 to 796 1 to 672 exact     672/674
(99 %)
2 diff
(99.8 %id)
DN997335 breast cancer, Mammary gland (cancer tissue) CHRAC1.a 128 to 886 1 to 759 exact     759/759
(100 %)
7 diff
(99.1 %id)
CR590458 placenta CHRAC1.a 132 to 2038 1 to 1907 exact tiling clone,   1907/1907
(100 %)
0 diff
(100 %id)
BX417908 placenta CHRAC1.a 132 to 1225 1 to 1082 exact fully sequenced,   1082/1082
(100 %)
18 diff
(98.4 %id)
BX107994 whole brain CHRAC1.a 136 to 611 1 to 475 E113X     475/477
(99 %)
2 diff
(99.6 %id)
BG703474 brain, hippocampus CHRAC1.a 139 to 964 1 to 822 K69T K70E V71S L72T T73D ...     822/834
(98 %)
22 diff
(97.4 %id)
BP221400 colon CHRAC1.a 144 to 701 1 to 558 H126R     558/558
(100 %)
5 diff
(99.2 %id)
AL701705 human skeletal muscle CHRAC1.a 144 to 721 1 to 577 exact     577/577
(100 %)
4 diff
(99.4 %id)
BM828666 Ascites, stomach CHRAC1.a 144 to 465 1 to 322       322/322
(100 %)
3 diff
(99.1 %id)
DA263553 caudate nucleus CHRAC1.a 145 to 708 2 to 565 exact capped   564/566
(99 %)
1 diff
(99.9 %id)
DA894905 skeletal muscle CHRAC1.a 145 to 711 2 to 568 R25Q capped   567/567
(100 %)
2 diff
(99.7 %id)
BX428193 adult brain, brain CHRAC1.a 146 to 1149 33 to 1025 S22X G66E K67R E68K K69R ... fully sequenced, AAA   993/1025
(96 %)
22 diff
(97.9 %id)
DB471968 hippocampus CHRAC1.a 146 to 640 1 to 495 exact     495/495
(100 %)
0 diff
(100 %id)
CN360555 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CHRAC1.a 149 to 826 1 to 678 exact     678/678
(100 %)
3 diff
(99.6 %id)
BC015891 Uterus, leiomyosarcoma CHRAC1.a 156 to 2042 1 to 1883 exact available from MGC, AAA   1883/1883
(100 %)
6 diff
(99.7 %id)
CX762376 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CHRAC1.a 157 to 929 1 to 773 exact   Submitted on the opposite strand 773/775
(99 %)
1 diff
(99.9 %id)
CR605303 Placenta Cot 25-normalized CHRAC1.a 163 to 2015 1 to 1853 exact     1853/1853
(100 %)
0 diff
(100 %id)
AL553037 placenta, Placenta Cot 25-normalized CHRAC1.a 163 to 1101 1 to 936 E33R V34C S35P S36A I37S ... fully sequenced, AAA   936/936
(100 %)
14 diff
(98.6 %id)
BI668508 brain, hypothalamus CHRAC1.a 165 to 1087 1 to 915 exact     915/924
(99 %)
48 diff
(94.9 %id)
BG701496 brain, hippocampus CHRAC1.a 169 to 966 1 to 801 E50V L51A F52L V53C Q54S ...     799/801
(99 %)
22 diff
(97.3 %id)
BG701340 brain, hippocampus CHRAC1.a 169 to 943 1 to 775 Q88H F89V L90S A91C D92R ...     775/787
(98 %)
20 diff
(97.5 %id)
TI_44344679   CHRAC1.a 170 to 1087 87 to 996 exact     910/1005
(90 %)
50 diff
(95.1 %id)
BX641822   CHRAC1.a 173 to 891 1 to 718 exact     718/724
(99 %)
4 diff
(99.5 %id)
BE544912 cervical carcinoma cell line, cervix CHRAC1.a 174 to 794 1 to 639       622/896
(69 %)
46 diff
(94.9 %id)
BU188799 melanotic melanoma, skin CHRAC1.a 174 to 1053 1 to 880 exact     880/882
(99 %)
17 diff
(98.1 %id)
DB012625 esophageal, tumor tissue CHRAC1.a 175 to 737 2 to 564 exact capped   563/563
(100 %)
1 diff
(99.9 %id)
AW953245   CHRAC1.a 179 to 748 1 to 573 L99X     573/577
(99 %)
7 diff
(98.8 %id)
CD707982 normal nasopharynx CHRAC1.a 180 to 713 39 to 572 L99S N122H E123D     534/572
(93 %)
12 diff
(98.0 %id)
BX446401 placenta CHRAC1.a 183 to 1255 1 to 1066 K8E S84*     1066/1069
(99 %)
17 diff
(98.5 %id)
AF226076   CHRAC1.a 195 to 590 1 to 396 exact     396/396
(100 %)
0 diff
(100 %id)
CV023302 mixed CHRAC1.a 195 to 595 1 to 400 exact     400/542
(73 %)
4 diff
(99.3 %id)
BQ050026 lymph, lymphoma, cell line CHRAC1.a 197 to 819 1 to 630       630/1442
(43 %)
20 diff
(98.7 %id)
R55966 whole brain CHRAC1.a 200 to 577 1 to 382       382/392
(97 %)
16 diff
(96.0 %id)
AV760098 bone marrow CHRAC1.a 220 to 902 1 to 677       677/695
(97 %)
28 diff
(96.0 %id)
AI823850 2 pooled tumors (clear cell type), Kidney CHRAC1.a 237 to 471 522 to 288       235/522
(45 %)
0 diff
(100 %id)
AA969862 pooled CHRAC1.a 251 to 492 1 to 243     Submitted on the opposite strand 243/244
(99 %)
9 diff
(96.4 %id)
BE870745 adenocarcinoma, colon CHRAC1.a 254 to 962 1 to 706       706/706
(100 %)
9 diff
(98.8 %id)
AW840208 leiomios CHRAC1.a 275 to 448 172 to 1       172/172
(100 %)
7 diff
(96.0 %id)
AW674846 cervix CHRAC1.a 401 to 829 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
H80210 liver and spleen CHRAC1.a 465 to 772 1 to 309       309/309
(100 %)
4 diff
(98.8 %id)
BI224241 cervical carcinoma cell line, cervix CHRAC1.a 515 to 1329 1 to 812       812/898
(90 %)
26 diff
(97.2 %id)
BE932798 head_neck CHRAC1.a 539 to 754 4 to 219       216/219
(98 %)
6 diff
(97.3 %id)
AA625083 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CHRAC1.a 598 to 946 15 to 362       348/362
(96 %)
6 diff
(98.4 %id)
BU198388   CHRAC1.a 635 to 1190 1 to 556       556/556
(100 %)
11 diff
(98.1 %id)
BG105374 adrenal cortex carcinoma, cell line, adrenal gland CHRAC1.a 648 to 1335 1 to 684       684/939
(72 %)
18 diff
(98.1 %id)
BG740072 skin CHRAC1.a 661 to 1323 1 to 662       662/662
(100 %)
5 diff
(99.3 %id)
BE868918 adenocarcinoma, colon CHRAC1.a 677 to 1447 1 to 765       765/840
(91 %)
44 diff
(94.8 %id)
AW630300 2 pooled high-grade transitional celltumors, genitourinary tract CHRAC1.a 692 to 1119 10 to 436       427/436
(97 %)
6 diff
(98.7 %id)
DB534337 hippocampus CHRAC1.a 722 to 1131 1 to 409     Submitted on the opposite strand 409/409
(100 %)
1 diff
(99.8 %id)
CA438405 lung, Metastatic Chondrosarcoma CHRAC1.a 741 to 1322 600 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 582/582
(100 %)
0 diff
(100 %id)
BG290482 bladder, transitional cell papilloma, cell line CHRAC1.a 784 to 1497 1 to 711       711/748
(95 %)
14 diff
(98.2 %id)
BG026185 Bone, osteosarcoma, cell line CHRAC1.a 787 to 1498 1 to 710       710/920
(77 %)
20 diff
(97.9 %id)
BF672628 muscle (skeletal) CHRAC1.a 791 to 1447 1 to 647       647/785
(82 %)
21 diff
(97.4 %id)
BE872038 adenocarcinoma, colon CHRAC1.a 803 to 1553 1 to 751       751/779
(96 %)
21 diff
(97.4 %id)
BF242584 bone marrow, from acute myelogenous leukemia CHRAC1.a 875 to 1503 1 to 631       631/744
(84 %)
25 diff
(96.7 %id)
AI687989 pooled CHRAC1.a 883 to 1204 325 to 4       322/325
(99 %)
0 diff
(100 %id)
BF795720 lymph, lymphoma, cell line CHRAC1.a 931 to 1546 1 to 610       610/612
(99 %)
14 diff
(97.8 %id)
AA402539 ovarian tumor, ovary CHRAC1.a 969 to 1426 1 to 458       458/458
(100 %)
3 diff
(99.4 %id)
BF038864 adenocarcinoma, ovary CHRAC1.a 975 to 1604 1 to 624       624/644
(96 %)
26 diff
(96.0 %id)
BX390617   CHRAC1.a 1016 to 1953 1 to 933       933/933
(100 %)
19 diff
(98.0 %id)
AL576154 placenta, Placenta Cot 25-normalized CHRAC1.a 1024 to 2014 983 to 1   fully sequenced,   983/983
(100 %)
20 diff
(98.0 %id)
BP326011 prostata CHRAC1.a 1033 to 1608 1 to 578       578/584
(98 %)
20 diff
(96.6 %id)
BX340935   CHRAC1.a 1049 to 2013 957 to 1       957/957
(100 %)
16 diff
(98.4 %id)
AA383884 thymus CHRAC1.a 1053 to 1222 1 to 170       170/170
(100 %)
0 diff
(100 %id)
BM837619 Ascites, stomach CHRAC1.a 1060 to 1768 1 to 707       707/707
(100 %)
4 diff
(99.5 %id)
BI856068 breast, mammary adenocarcinoma, cell line CHRAC1.a 1065 to 1777 1 to 706       706/711
(99 %)
18 diff
(97.5 %id)
TI_57186550   CHRAC1.a 1065 to 1777 54 to 759       706/711
(99 %)
18 diff
(97.5 %id)
AL576145 placenta, Placenta Cot 25-normalized CHRAC1.a 1071 to 2015 946 to 1   fully sequenced,   946/946
(100 %)
18 diff
(98.1 %id)
AA482426.
matches multiple genes
ovarian tumor, ovary CHRAC1.a 1080 to 1654 1 to 573     also hits gene IQCK 573/573
(100 %)
5 diff
(99.2 %id)
AW959284   CHRAC1.a 1087 to 1672 1 to 582       582/585
(99 %)
31 diff
(94.8 %id)
BF348189 anaplastic oligodendroglioma with 1p/19qloss, brain CHRAC1.a 1091 to 1684 5 to 591       587/906
(64 %)
17 diff
(98.2 %id)
BX428192 adult brain, brain CHRAC1.a 1119 to 2032 901 to 1   fully sequenced,   901/901
(100 %)
16 diff
(98.3 %id)
BM806868 duodenal adenocarcinoma, cell line, small intestine CHRAC1.a 1126 to 1831 1 to 713       713/1061
(67 %)
20 diff
(98.2 %id)
BM055390 Islets of Langerhans, Pancreas CHRAC1.a 1156 to 1673 1 to 517       517/517
(100 %)
3 diff
(99.5 %id)
BE674784 B-cell, chronic lymphotic leukemia CHRAC1.a 1159 to 1321 163 to 1       436/486
(89 %)
28 diff
(94.3 %id)
BX343600.
matches multiple genes
placenta, Placenta Cot 25-normalized CHRAC1.a 1162 to 2020 854 to 1     also hits gene SLC39A13 854/854
(100 %)
12 diff
(98.6 %id)
BG760612 melanotic melanoma, high MDR (cell line), skin CHRAC1.a 1175 to 1883 1 to 715       715/893
(80 %)
28 diff
(96.9 %id)
BG765612 melanotic melanoma, high MDR (cell line), skin CHRAC1.a 1175 to 2035 1 to 871       871/937
(92 %)
71 diff
(92.5 %id)
BM928747 hepatocellular carcinoma, cell line, Liver CHRAC1.a 1175 to 2040 19 to 888       870/1048
(83 %)
6 diff
(99.5 %id)
BX412485 placenta CHRAC1.a 1195 to 2037 849 to 1   fully sequenced,   849/849
(100 %)
26 diff
(97.0 %id)
CB132524 Liver CHRAC1.a 1239 to 1732 1 to 488       488/488
(100 %)
6 diff
(98.8 %id)
FN117055 breast carcinoma CHRAC1.a 1263 to 1322 1 to 61       61/61
(100 %)
2 diff
(96.8 %id)
TI_151759687   CHRAC1.a 1267 to 2043 905 to 135       771/1018
(75 %)
0 diff
(100 %id)
R92055 liver and spleen CHRAC1.a 1286 to 1607 12 to 332       321/332
(96 %)
6 diff
(98.2 %id)
BU616549 Cell Line, Chondrosarcoma CHRAC1.a 1311 to 2042 750 to 19   AAA   732/733
(99 %)
4 diff
(99.5 %id)
BP431301   CHRAC1.a 1333 to 1682 1 to 351       351/351
(100 %)
9 diff
(97.5 %id)
AW404354 lymph CHRAC1.a 1347 to 1742 1 to 395       395/395
(100 %)
7 diff
(98.3 %id)
TI_154141258   CHRAC1.a 1353 to 1851 80 to 577       498/498
(100 %)
8 diff
(98.4 %id)
DA231538 brain CHRAC1.a 1360 to 1896 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
CA421563 Bone, Enchondroma cell line CHRAC1.a 1401 to 2042 660 to 19   AAA   642/657
(97 %)
2 diff
(99.7 %id)
BI855635 breast, mammary adenocarcinoma, cell line CHRAC1.a 1434 to 2035 13 to 624       612/674
(90 %)
45 diff
(93.4 %id)
TI_57186265   CHRAC1.a 1434 to 2035 72 to 683       612/847
(72 %)
45 diff
(94.7 %id)
CF130755 Chondrosarcoma Lung Metastasis cell lines, lung CHRAC1.a 1466 to 2042 1 to 576   AAA   576/576
(100 %)
1 diff
(99.9 %id)
TI_154192774   CHRAC1.a 1466 to 2042 51 to 626   AAA   576/576
(100 %)
1 diff
(99.9 %id)
C75277   CHRAC1.a 1505 to 2043 540 to 9       532/540
(98 %)
0 diff
(100 %id)
AW337141 adenocarcinoma, Pancreas CHRAC1.a 1534 to 2042 509 to 1       509/509
(100 %)
0 diff
(100 %id)
DB550858 hippocampus CHRAC1.a 1539 to 2042 1 to 505     Submitted on the opposite strand 505/505
(100 %)
1 diff
(99.9 %id)
DB540720 hippocampus CHRAC1.a 1554 to 2041 1 to 488     Submitted on the opposite strand 488/489
(99 %)
1 diff
(99.8 %id)
DB527744 testis CHRAC1.a 1589 to 2042 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
R55967 whole brain CHRAC1.a 1591 to 2024 442 to 1       442/442
(100 %)
17 diff
(96.2 %id)
DB513207 testis CHRAC1.a 1596 to 2042 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
AW089963 ovary, tumor, 5 pooled (see description) CHRAC1.a 1616 to 2042 440 to 13   AAA   428/428
(100 %)
6 diff
(98.6 %id)
AW673980 cervix CHRAC1.a 1616 to 2043 430 to 3       428/430
(99 %)
0 diff
(100 %id)
AW473946 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus CHRAC1.a 1623 to 2043 422 to 2       421/429
(98 %)
0 diff
(100 %id)
AW338567 adenocarcinoma, Pancreas CHRAC1.a 1629 to 1964 414 to 79       336/414
(81 %)
0 diff
(100 %id)
AI476554 colon, moderately-differentiated adenocarcinoma CHRAC1.a 1631 to 2043 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AA099200 colon, tumor CHRAC1.a 1673 to 2062 14 to 411     Submitted on the opposite strand 398/411
(96 %)
6 diff
(98.6 %id)
AA350347 brain CHRAC1.a 1682 to 2042 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AI860119 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors CHRAC1.a 1690 to 2043 359 to 5       355/359
(98 %)
0 diff
(100 %id)
C13977   CHRAC1.a 1693 to 2042 350 to 1       350/380
(92 %)
2 diff
(99.5 %id)
AI832578 colon CHRAC1.a 1713 to 2042 330 to 1       330/330
(100 %)
0 diff
(100 %id)
D19659   CHRAC1.a 1729 to 2043 1 to 316     Submitted on the opposite strand 316/318
(99 %)
7 diff
(97.8 %id)
AA837119 germinal center B cell CHRAC1.a 1747 to 2043 324 to 28       297/466
(63 %)
0 diff
(100 %id)
BI011169 lung_normal CHRAC1.a 1755 to 1973 1 to 219       219/219
(100 %)
0 diff
(100 %id)
AI718191 aorta CHRAC1.a 1773 to 2042 270 to 1       270/270
(100 %)
0 diff
(100 %id)
AW082498 esophagus, squamous cell carcinoma CHRAC1.a 1788 to 2044 266 to 10       257/266
(96 %)
0 diff
(100 %id)
AW615054 2 pooled high-grade transitional celltumors, genitourinary tract CHRAC1.a 1792 to 2043 255 to 4       252/255
(98 %)
0 diff
(100 %id)
R77592 placenta CHRAC1.a 1927 to 2376 1 to 459       459/461
(99 %)
16 diff
(96.6 %id)
AA988299 breast CHRAC1.a 1967 to 2497 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
AU156507 placenta CHRAC1.a 2090 to 2496 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
AI190128 heart CHRAC1.a 2115 to 2497 385 to 3       383/385
(99 %)
0 diff
(100 %id)
AA102023 colon, tumor CHRAC1.a 2126 to 2497 374 to 3   tiling clone, Submitted on the opposite strand 372/374
(99 %)
0 diff
(100 %id)
BF510286   CHRAC1.a 2156 to 2497 356 to 15       342/356
(96 %)
0 diff
(100 %id)
AL579807 T cells from T cell leukemia CHRAC1.a 2210 to 2424 246 to 32       215/232
(92 %)
0 diff
(100 %id)
AL543044 placenta, Placenta Cot 25-normalized CHRAC1.b 1 to 798 1 to 802 exact tiling clone,   802/806
(99 %)
14 diff
(98.3 %id)
BG679861 skin, squamous cell carcinoma CHRAC1.b 6 to 747 1 to 736 exact     736/736
(100 %)
7 diff
(99.1 %id)
NR_023360.1   CHRAC1.b 6 to 2364 1 to 2359 exact RefSeq, tiling clone,   2359/2359
(100 %)
0 diff
(100 %id)
AK308709 amygdala CHRAC1.b 118 to 1678 1 to 1558 exact     1558/1558
(100 %)
7 diff
(99.6 %id)
DC313125 amygdala CHRAC1.b 118 to 680 1 to 567 G12W E13G Q14A R15A L16A ...     567/568
(99 %)
9 diff
(98.5 %id)
AL557850 T cells from T cell leukemia CHRAC1.b 141 to 1194 34 to 1078 exact     1045/1088
(96 %)
24 diff
(97.8 %id)
CN360556 embryonic stem cells, cell lines H1, H7, andH9 CHRAC1.b 153 to 606 19 to 472 exact     454/472
(96 %)
9 diff
(98.1 %id)
BE159040 head_neck CHRAC1.b 185 to 657 1 to 473 D3H     473/473
(100 %)
8 diff
(98.4 %id)
BE158974 head_neck CHRAC1.b 206 to 661 477 to 23     Submitted on the opposite strand 455/477
(95 %)
0 diff
(100 %id)
BE158978 head_neck CHRAC1.b 206 to 657 1 to 452       452/452
(100 %)
2 diff
(99.6 %id)
BE158979 head_neck CHRAC1.b 206 to 662 468 to 13     Submitted on the opposite strand 456/468
(97 %)
0 diff
(100 %id)
BE159028 head_neck CHRAC1.b 206 to 661 464 to 8     Submitted on the opposite strand 457/464
(98 %)
0 diff
(100 %id)
BE159121 head_neck CHRAC1.b 206 to 662 470 to 16     Submitted on the opposite strand 455/470
(96 %)
1 diff
(99.8 %id)
BE159086 head_neck CHRAC1.b 210 to 670 469 to 9     Submitted on the opposite strand 461/473
(97 %)
16 diff
(96.7 %id)
AL569833 placenta, Placenta Cot 25-normalized CHRAC1.b 1070 to 1887 820 to 1       820/899
(91 %)
39 diff
(95.7 %id)
AK311595 testis CHRAC1.c 1 to 926 2 to 927 exact tiling clone,   927/927
(100 %)
2 diff
(99.8 %id)
DB054918 testis CHRAC1.c 1 to 566 2 to 567 exact capped   566/566
(100 %)
2 diff
(99.7 %id)
BM719279 eye, fetal eye CHRAC1.c 379 to 913 1 to 535 exact     535/535
(100 %)
0 diff
(100 %id)
BF085508 placenta_normal CHRAC1.c 655 to 988 17 to 348       332/348
(95 %)
6 diff
(98.3 %id)
BQ365769 placenta_normal CHRAC1.c 663 to 988 1 to 324   tiling clone,   324/324
(100 %)
9 diff
(97.3 %id)
CK430097 eye, lacrimal gland CHRAC1.d 1 to 618 1 to 618   tiling clone,   618/618
(100 %)
1 diff
(99.9 %id)
AW361953 colon CHRAC1.d 116 to 505 410 to 21       390/415
(93 %)
1 diff
(99.8 %id)
BU618474 Cell Line, Chondrosarcoma CHRAC1.d 152 to 888 753 to 19 exact tiling clone, AAA   735/735
(100 %)
6 diff
(99.2 %id)
EH341034   CHRAC1.d 153 to 220 1 to 68       68/68
(100 %)
1 diff
(98.6 %id)
BU160855 bone marrow, from acute myelogenous leukemia CHRAC1.e 1 to 814 1 to 822 W35R A45G R46K Q52P D56H ... tiling clone,   822/822
(100 %)
36 diff
(95.7 %id)
DC354669 lung CHRAC1.e 4 to 576 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DB264865 uterus CHRAC1.e 19 to 591 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ430577 embryonal carcinoma, cell line, testis CHRAC1.e 36 to 774 1 to 748 P22A Q29P L40S Q41P T42P ... tiling clone,   748/935
(80 %)
29 diff
(96.9 %id)
DB467340 hippocampus CHRAC1.f-u 1 to 446 1 to 444 L94S V95S tiling clone,   444/444
(100 %)
3 diff
(99.4 %id)
DB448027 testis CHRAC1.f-u 8 to 437 1 to 430       430/434
(99 %)
1 diff
(99.8 %id)
DB462308 testis CHRAC1.f-u 8 to 475 1 to 468   tiling clone,   468/468
(100 %)
0 diff
(100 %id)
BX372699 Neuroblastoma Cot 25-normalized Gene CHRAC1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BX394092 Neuroblastoma Cot 25-normalized Gene CHRAC1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BI758554 brain Gene CHRAC1, variant not shown         This clone was ignored    
BM015832 breast, mammary adenocarcinoma, cell line Gene CHRAC1, variant not shown         This clone was ignored    
TI_57215691   Gene CHRAC1, variant not shown         This clone was ignored    
TI_59394191   Gene CHRAC1, variant not shown         This clone was ignored    
AU158940 thyroid gland Gene CHRAC1, variant not shown         Suspected internal deletion, this clone was ignored    
DC424703 thyroid gland Gene CHRAC1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI